Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy.
Dermatitis
; 33(3): e25-e29, 2022.
Article
in English
| MEDLINE | ID: covidwho-1672329
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
/
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Dermatitis
Journal subject:
Dermatology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS